Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Integra Lifesciences Holdings (IART) Other financing activities (2016 - 2025)

Integra Lifesciences Holdings' Other financing activities history spans 14 years, with the latest figure at $134000.0 for Q4 2025.

On a quarterly basis, Other financing activities changed N/A to $134000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $209000.0, a N/A change, with the full-year FY2025 number at $4.1 million, changed N/A from a year prior.
Other financing activities hit $134000.0 in Q4 2025 for Integra Lifesciences Holdings, up from $75000.0 in the prior quarter.
Over the last five years, Other financing activities for IART hit a ceiling of $7.6 million in Q1 2023 and a floor of $75000.0 in Q3 2025.
Historically, Other financing activities has averaged $1.7 million across 3 years, with a median of $249000.0 in 2021.